MedPath

Effectiveness Study of Integrative Treatment for Pediatric Pneumonia

Not Applicable
Completed
Conditions
Pneumonia
Interventions
Registration Number
NCT02069665
Lead Sponsor
Liaoning University of Traditional Chinese Medicine
Brief Summary

The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial.

Detailed Description

The retrospective case study has been finished at the National clinical research base of traditional Chinese medicine for major disease pediatric pneumonia, and the research center organized the field training of prospective-study to coordinated units. Based on the primary statistical outcomes of retrospective case study and the discussion around prospective-study during the training, investigators found it difficult to include simplex viral infection, therefore, investigators revised the inclusion criteria and treatment protocol of the pragmatic randomized controlled trial.

The block randomization is used in this trial. Random numbers are generated by SPSS software. Statistical analysis staff and those who perform the follow-up are blinded. Sample size calculation was performed, which was 369, and considering drop-out or withdrawal, investigators plan to enroll 450 patients (300 in experimental group, 150 in control).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
451
Inclusion Criteria
  • children, aged 6 months to 59 months old, diagnosed as pneumonia according to western medicine diagnostic criteria;
  • diagnosed as TCM pneumonia with gasp-cough, meeting wind-heat blocking lungs pattern (feng re bi fei zheng), and phlegm-heat blocking lungs pattern (tan re bi fei zheng);
  • disease progression within 72 hours;
  • those whose guardians understood and assigned the informed consent;
Exclusion Criteria
  • emergency pneumonia;
  • complicated with other Pulmonary Disorders attack other than pneumonia;
  • complicated with primary disease of heart (congenital heart disease, myocarditis, et al), liver (ALT, and AST ≥ 1.5 times of normal value ceiling), kidney (BUN > 8.2mmol/L, or serum CR > 104 µmol/L, et al) and blood system (anemia), and those with psychopathy;
  • allergic to interventional medications;
  • those who are participating or have participated in other clinical trials in 3 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Injection and medicationsIbuprofen SuspensionIntravenous injection: Ribavirin Injection; Medications: symptomatic therapies * Guaifenesin Syrup, for removing phlegm, relieving gasp-cough; * Ibuprofen Suspension, and salbutamol in case of different symptoms
Injection, medications and applicationFuxiong SanIntravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd; Medications: according to TCM syndrome differentiations; * Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough) * Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm) External application: Fuxiong San
Injection, medications and applicationZhi Ke SanIntravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd; Medications: according to TCM syndrome differentiations; * Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough) * Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm) External application: Fuxiong San
Injection, medications and applicationHua Tan SanIntravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd; Medications: according to TCM syndrome differentiations; * Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough) * Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm) External application: Fuxiong San
Injection and medicationsRibavirin InjectionIntravenous injection: Ribavirin Injection; Medications: symptomatic therapies * Guaifenesin Syrup, for removing phlegm, relieving gasp-cough; * Ibuprofen Suspension, and salbutamol in case of different symptoms
Injection and medicationsGuaifenesin SyrupIntravenous injection: Ribavirin Injection; Medications: symptomatic therapies * Guaifenesin Syrup, for removing phlegm, relieving gasp-cough; * Ibuprofen Suspension, and salbutamol in case of different symptoms
Injection and medicationssalbutamolIntravenous injection: Ribavirin Injection; Medications: symptomatic therapies * Guaifenesin Syrup, for removing phlegm, relieving gasp-cough; * Ibuprofen Suspension, and salbutamol in case of different symptoms
Injection, medications and applicationXiyanping injectionIntravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd; Medications: according to TCM syndrome differentiations; * Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough) * Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm) External application: Fuxiong San
Injection, medications and applicationXiaoer Qingfei Heji (mixture)Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd; Medications: according to TCM syndrome differentiations; * Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough) * Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm) External application: Fuxiong San
Primary Outcome Measures
NameTimeMethod
Cured rateEvery day since receiving treatment, all together 10 days (times)

Clinical symptoms and signs totally disappear, the period of lab tests return to normal is recorded.

Effectiveness time windowEvery day since receiving treatment, all together 10 days (times)

days range from treatment is received to the effectiveness is observed, and symptoms disappear

Secondary Outcome Measures
NameTimeMethod
TCM syndrome scores and effective rate10 days

Total effective rate according to TCM syndrome differentiation and treatment, and single syndrome effective rate

Effect in fever, cough, phlegm and gasp10 days

temperature, fever frequency, fever lasting time, Ibuprofen Suspension dosing; cough severity; phlegm amount, color and nature; gasp frequency, severity, all to be measured

Time of lung rales disappear completely10 days

days are counted since receiving treatment, when the chest radiograph returns to normal

Check-out time10 days

days counted when the patient checks out

Pulmonary disease incidence30 days

unresolved pneumonia, chronic cough, cough variant asthma incidence in the follow-up

Trial Locations

Locations (6)

Affiliated Children's Hospital of Capital University of Medical Sciences

🇨🇳

Beijing, Beijing, China

Affiliated Children's Hospital of Dalian Medical University

🇨🇳

Dalian, Liaoning, China

Affiliated Hospital of Liaoning University of TCM

🇨🇳

Shenyang, Liaoning, China

Guangzhou Children's Hospital

🇨🇳

Guangzhou, Guangdong, China

Affiliated Hospital of Shandong University of TCM

🇨🇳

Ji'nan, Shandong, China

Affiliated Longhua Hospital of Shanghai University of TCM

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath